Circulating Cell-Free Microbial DNA Signatures and Plasma Soluble CD14 Level Are Associated with Clinical Outcomes of Anti-PD-1 Therapy in Advanced Melanoma Patients
Bernadeta Drymel, Katarzyna Tomela, Łukasz Galus, Agnieszka Olejnik-Schmidt, Jacek Mackiewicz, Mariusz Kaczmarek, Andrzej Mackiewicz, Marcin Schmidt, Terrence Piva · 2024
Read Circulating Cell-Free Microbial DNA Signatures and Plasma Soluble CD14 Level Are Associated with Clinical Outcomes of Anti-PD-1 Therapy in Advanced Melanoma Patients by Bernadeta Drymel, Katarzyna Tomela, Łukasz Galus, Agnieszka Olejnik-Schmidt, Jacek Mackiewicz, Mariusz Kaczmarek, Andrzej Mackiewicz, Marcin Schmidt, Terrence Piva (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11641495.txt.
Description
Bernadeta Drymel and co-authors read microbe DNA in blood to predict melanoma therapy outcomes in a 2024 study. Free microbial DNA drifts in the blood of cancer patients. It may mirror gut microbes leaking into circulation. A companion protein, soluble CD14, rises when myeloid cells meet such ligands.
Blood came from 66 patients before and during anti-PD-1 therapy. Gene sequencing profiled the microbial DNA, and an assay measured the protein. Baseline patterns split patients by later outcome. Signatures tied to progression-free and overall survival. The protein ran higher in one outcome group. The pair may serve as a non-invasive forecast for immunotherapy.
Catalog record
| CREATOR | Bernadeta Drymel, Katarzyna Tomela, Łukasz Galus, Agnieszka Olejnik-Schmidt, Jacek Mackiewicz, Mariusz Kaczmarek, Andrzej Mackiewicz, Marcin Schmidt, Terrence Piva |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 65 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |